2,5-Cyclohexadiene-1,4-dione, 2-(2,5-dichlorophenyl)-, 98%, 250mg

N-(4-hydroxyphenyl)butyramide, 98%, 100g

Nazartinib, 1mg

6-(1H-Pyrazol-1-yl)nicotinic acid, 95.0%, 25g

Fmoc-D-Bip(4,4�)-OH, 25g

O-(6-Chlorobenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium Tetrafluoroborate>98.0%(HPLC)(qNMR)25g

Triphenyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)silane, 98%, 1g

8-Bromo-6-fluoroquinoline, 95.0%, 1g

2,2,4-Trimethylpentane [for Spectrophotometry]>99.0%(GC)250mL

Methyl 2-(3-bromophenyl)-2,2-difluoroacetate, 97%, 100mg

2-Bromo-2'-methylacetophenone>96.0%(GC)(T)1g

2,2,2-Trifluoro-N-isopropylacetamide, 98%, 5g

5-Ethynyl-1,2,3-trimethoxybenzene, 98%, 250mg